Nitrosamine unintended chemicals are unwanted by-products that can form during the manufacturing, storage, or degradation of certain drugs. These nitrosated health-risk compounds present potential nitrosated hazards due to their genotoxic potential and nitrosated exposure risks, making them a significant concern in pharmaceuticals. Effective nitrosated impurity monitoring and nitrosated impurities testing, along with thorough toxicology of nitrosated substances and risk evaluation of nitrosated agents, are essential. Evaluating nitrosated agents in products and nitrosated compound characterization ensure accurate assessment and control to protect patient safety.
Manasa Life Sciences is a globally recognized manufacturer and supplier of nitrosamine-associated impurities, providing scientifically validated reference standards to support pharmaceutical development and regulatory compliance. The company specializes in nitrosamine process impurities, unintended chemicals, and N-nitroso or nitroso-derived compounds for analytical testing, method validation, and quality assurance. Its product range includes regulated nitrosamines such as NDMA, NDEA, NDPA, and NDBA, all delivered with verified structural data and certificates of analysis. With high-purity materials, rapid processing, regulatory documentation, and expert technical support, Manasa Life Sciences ensures reliable supply, traceability, and compliance for pharmaceutical manufacturers, CROs, and research laboratories worldwide.